79 results
424B5
NBSE
NeuBase Therapeutics Inc
30 Jun 23
Prospectus supplement for primary offering
8:42am
, disqualification, retirement or removal of a director, which prevents stockholders from being able to fill vacancies on our board of directors
424B5
0cd s3x5y
29 Dec 22
Prospectus supplement for primary offering
5:03pm
8-K
EX-10.1
dkz0cz9ptv1uqhw26o7
1 Oct 21
Departure of Directors or Certain Officers
4:17pm
424B5
pomymtvdzv58qzzr zpp
27 Aug 21
Prospectus supplement for primary offering
5:21pm
8-K
EX-1.1
qc02lgq3
27 Aug 21
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
lf80raulp x68eitg6l2
20 May 21
NeuBase Therapeutics Appoints Dr. Sandra Rojas-Caro Chief Medical Officer
9:00am
424B5
ib837c9ntf nn1q
23 Apr 21
Prospectus supplement for primary offering
4:05pm
8-K
EX-1.1
3owh86z k2ox
22 Apr 21
NeuBase Therapeutics Announces Pricing of $40 Million Public Offering of Common Stock
9:33am
424B5
0lxpa rzbjm0
21 Apr 21
Prospectus supplement for primary offering
4:03pm